Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Family Medicine
Clinical Trials: Dermatitis, Atopic
A listing of clinical trials currently looking for volunteers to enroll in Dermatitis, Atopic studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Mobile :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Arizona
Hot Springs :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
California
Encino : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Oceanside : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
San Diego : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Colorado
Denver : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Florida
Jacksonville : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Miami : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Miami : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Miramar : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Orange Park :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
View More »
Pinellas Park :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Tampa :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Tampa : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Idaho
Boise : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Illinois
Arlington Heights :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Indiana
Carmel :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Michigan
Canton : Hamzavi Dermatology/Dermatology Specialists of Canton
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Fort Gratiot : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Fort Gratiot : Hamzavi Dermatology
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Minnesota
Fridley :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
New Jersey
Berlin :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Verona : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
New Mexico
Albuquerque : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
New York
Stony Brook : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Stony Brook : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
North Carolina
High Point :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Salem : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Winston-Salem : Wake Forest University Health Sciences
Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Ohio
South Euclid :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Sylvania : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Oregon
Lake Oswego : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Portland :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Portland : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Portland : Oregon Health & Science University Center for Health & Healing
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
Portland : Oregon Health & Science University, Department of Dermatology
Eczema Prevention Study
View More »
Portland : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Portland :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Portland : Oregon Health & Science University Department of Dermatology
VANOS Cream and Skin Barrier Function
Pennsylvania
Philadelphia : Registry
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
Pittsburgh : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Rhode Island
Johnston : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Tennessee
Knoxville : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Texas
Austin :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
College Station :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
College Station : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Dallas :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
San Antonio :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
View More »
San Antonio : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Webster : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Utah
Draper : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Salt Lake City : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Virginia
Henrico : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Norfolk : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Norfolk : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Washington
Spokane : Updated
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Australia
Box Hill : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Fremantle : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Kogarah : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Parkville : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Phillip : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
View More »
Wooloongabba : Anacor Investigational Site
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Austria
Vienna : Novartis Investigative Site
A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
Canada
Markham : Lynderm Research
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Windsor : Windsor Clinical Research
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
China
Beijing :
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Chongqing :
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Guangzhou :
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Shanghai :
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Czech Republic
Nachod :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Svitavy :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Usti nad Labem :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Finland
Helsinki :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Tampere :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Germany
Berlin : Charité - Universitätsmedizin Berlin
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Berlin :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Berlin :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Bonn : Klinik und Poliklinik für Dermatologie und Allergologie der Universität Bonn
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Bonn :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
View More »
Dresden :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Erfurt :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Essen : Universitätshautklinik Essen
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Frankfurt :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Frankfurt :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Frankfurt/Main : Department of Dermatology, Johann Wolfgang Goethe-University
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Gera : SRH Wald-Klinikum Gera gGmbH
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Gera :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Hamburg : Clinical Trial Center North
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Hannover : Medizinische Hochschule Hannover
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Hannover :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Heidelberg :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Kiel :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Mahlow :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Mainz :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Münster : Universitätshautklinik Münster
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Münster :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Osnabrueck :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Tuebingen :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Hungary
Kaposvar :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Szeged :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Szekszard :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Szolnok :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Poland
Bydgoszcz :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Gdansk :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Lodz :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Lublin :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Poznan :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
View More »
Warszawa :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Warszawa :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Witosa :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Wroclaw :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Sweden
Stockholm : Sophiahemmet
Effect of Moisturizing Creams on Skin Barrier Function
Taiwan
United Kingdom
Leeds : Covance Clinical Research Unit Ltd.
Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102
Manchester : Local Institution
A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis
